The companies BridgeBio, Erasca, Chai Discovery, and MeiraGTx bagged the biggest biotech funding rounds overall in July 2026.

We look at some of the top companies that are investigating CAR-T therapies in clinical trials for autoimmune diseases.

About half of people with gout don't have treatments that work. Meet the new gout drugs racing through trials to reach them.

The only TIL therapy approved so far is Amtagvi for melanoma. Here are six companies with promising TIL therapies in the ...

Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry.

Research in the field of inflammatory diseases has become one of the hottest areas of drug development, spurred on by an interest in novel therapies that have the potential to be more precise and more ...

Radioligand therapy has been around for a long time, but 2025 was the year it started to look less like a niche tool and more like something oncology teams have to actively plan for. In March 2025, ...

You may already be familiar with protein degraders, drugs designed to eliminate disease-causing proteins, which have shown promising activity as cancer therapies. But have you heard of Regulated ...

In the heat of the COVID-19 crisis, a wave of vaccine companies stepped into the spotlight with unprecedented speed and visibility. Riding a surge of public and private funding, they raced to develop ...

There was a time when the numbers told an unoptimistic story about Roche. Its three oncology blockbusters, Herceptin, Avastin, and Rituxan, had built it into the world’s largest cancer drug maker, ...

Today, Akribion Therapeutics, a German biotech company announced its €8 million ($8.2 million) seed round. Akribion Therapeutics is working on G-dase E, a programmable nuclease designed to selectively ...